186 related articles for article (PubMed ID: 37436333)
1. Surgical Approaches for Repigmenting Vitiligo 2.0.
Passeron T
J Invest Dermatol; 2023 Nov; 143(11):2099-2101. PubMed ID: 37436333
[No Abstract] [Full Text] [Related]
2. Growth defects of melanocytes in culture from vitiligo subjects are spontaneously corrected in vivo in repigmenting subjects and can be partially corrected by the addition of fibroblast-derived growth factors in vitro.
Puri N; Mojamdar M; Ramaiah A
Arch Dermatol Res; 1989; 281(3):178-84. PubMed ID: 2774645
[TBL] [Abstract][Full Text] [Related]
3. Transplantation of in vitro-cultured epidermis bearing melanocytes for repigmenting vitiligo.
Falabella R; Escobar C; Borrero I
J Am Acad Dermatol; 1989 Aug; 21(2 Pt 1):257-64. PubMed ID: 2768575
[TBL] [Abstract][Full Text] [Related]
4. Is targeted UVB as effective as excimer light phototherapy in treatment of vitiligo?
Tabassum H; Majid I; Imran S
Dermatol Ther; 2021 Sep; 34(5):e15058. PubMed ID: 34245476
[TBL] [Abstract][Full Text] [Related]
5. Surgical approaches for stable vitiligo.
Falabella R
Dermatol Surg; 2005 Oct; 31(10):1277-84. PubMed ID: 16188179
[TBL] [Abstract][Full Text] [Related]
6. Vitiligo. Therapeutic advances.
Jimbow K
Dermatol Clin; 1998 Apr; 16(2):399-407. PubMed ID: 9589212
[TBL] [Abstract][Full Text] [Related]
7. Transcriptional Analysis of Vitiligo Skin Reveals the Alteration of WNT Pathway: A Promising Target for Repigmenting Vitiligo Patients.
Regazzetti C; Joly F; Marty C; Rivier M; Mehul B; Reiniche P; Mounier C; Rival Y; Piwnica D; Cavalié M; Chignon-Sicard B; Ballotti R; Voegel J; Passeron T
J Invest Dermatol; 2015 Dec; 135(12):3105-3114. PubMed ID: 26322948
[TBL] [Abstract][Full Text] [Related]
8. Grafting and transplantation of melanocytes for repigmenting vitiligo and other types of leukoderma.
Falabella R
Int J Dermatol; 1989; 28(6):363-9. PubMed ID: 2670786
[No Abstract] [Full Text] [Related]
9. Efficacy of narrowband ultraviolet B versus excimer radiation in repigmenting vitiligo after minigrafting on the distal arms.
Sheth VM; Currimbhoy SD; Feetham HJ; Graves MS; Chan J; Hynan LS; Pandya AG
J Am Acad Dermatol; 2012 Aug; 67(2):318-20. PubMed ID: 22794808
[No Abstract] [Full Text] [Related]
10. Treatment of localized vitiligo by autologous minigrafting.
Falabella R
Arch Dermatol; 1988 Nov; 124(11):1649-55. PubMed ID: 3052304
[TBL] [Abstract][Full Text] [Related]
11. Simplified cellular grafting for treatment of vitiligo and piebaldism: the "6-well plate" technique.
Goh BK; Chua XM; Chong KL; de Mil M; van Geel NA
Dermatol Surg; 2010 Feb; 36(2):203-7. PubMed ID: 20039922
[TBL] [Abstract][Full Text] [Related]
12. Etiology of vitiligo. A new hypothesis.
Ramaiah A; Puri N; Mojamdar M
Acta Derm Venereol; 1989; 69(4):323-6. PubMed ID: 2568052
[TBL] [Abstract][Full Text] [Related]
13. Assessment of Non-cultured Autologous Epidermal Cell Grafting Resuspended in Hyaluronic Acid for Repigmenting Vitiligo and Piebaldism Lesions: A Randomized Clinical Trial.
Bertolotti A; Leone G; Taïeb A; Soriano E; Pascal M; Maillard H; van Geel N
Acta Derm Venereol; 2021 Jul; 101(7):adv00506. PubMed ID: 34230975
[TBL] [Abstract][Full Text] [Related]
14. A prospective observational study to sequentially determine the dermoscopic features of vitiligo and its association with disease activity in patients on medical treatment: Dermoscopy and disease activity in vitiligo.
Gupta P; Vinay K; Bishnoi A; Kumaran MS; Parsad D
Pigment Cell Melanoma Res; 2023 Jan; 36(1):33-41. PubMed ID: 36112075
[TBL] [Abstract][Full Text] [Related]
15. Emerging drugs for the treatment of vitiligo.
Karagaiah P; Valle Y; Sigova J; Zerbinati N; Vojvodic P; Parsad D; Schwartz RA; Grabbe S; Goldust M; Lotti T
Expert Opin Emerg Drugs; 2020 Mar; 25(1):7-24. PubMed ID: 31958256
[No Abstract] [Full Text] [Related]
16. Sequential immunohistochemical study of depigmenting and repigmenting minigrafts in vitiligo.
Abdallah M; Abdel-Naser MB; Moussa MH; Assaf C; Orfanos CE
Eur J Dermatol; 2003; 13(6):548-52. PubMed ID: 14721774
[TBL] [Abstract][Full Text] [Related]
17. Treatment of vitiligo with oral methoxsalen and UVA.
Lassus A; Halme K; Eskelinen A; Ranki A; Puska P; Salo O
Photodermatol; 1984 Aug; 1(4):170-3. PubMed ID: 6531291
[TBL] [Abstract][Full Text] [Related]
18. Trichloroacetic Acid Cautery for Repigmenting Nonresponsive Vitiligo on Lips.
Mukhtar M
J Cutan Aesthet Surg; 2023; 16(2):154-155. PubMed ID: 37554674
[No Abstract] [Full Text] [Related]
19. Extracellular granular material and degeneration of keratinocytes in the normally pigmented epidermis of patients with vitiligo.
Moellmann G; Klein-Angerer S; Scollay DA; Nordlund JJ; Lerner AB
J Invest Dermatol; 1982 Nov; 79(5):321-30. PubMed ID: 7130745
[TBL] [Abstract][Full Text] [Related]
20. PUVA-induced repigmentation of vitiligo: a histochemical (split-DOPA) and ultrastructural study.
Ortonne JP; MacDonald DM; Micoud A; Thivolet J
Br J Dermatol; 1979 Jul; 101(1):1-12. PubMed ID: 113025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
